Structure Therapeutics Inc

Research Structure Therapeutics Inc (GPCR) on Bullrun: market cap USD 3.67B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGPCR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.67B
• Financial periodFY2025
• Net income-USD 141.20M
• Free cash flow-USD 225.81M

Valuation Snapshot

latest market cap is USD 3.67B.

About Structure Therapeutics Inc

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions.

Frequently asked questions

What is Structure Therapeutics Inc's market cap?

Structure Therapeutics Inc's market capitalization is USD 3.67B.

What does Structure Therapeutics Inc do?

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.